Amendment and Mail Process Complete

IRELYMI

AstraZeneca AB

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 97348836 FILING DATE 04/06/2022
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY TATE-NAGHI, JACQUELINE
L.O. ASSIGNED T70-NOT FOUND

PUB INFORMATION

RUN DATE 03/23/2023
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 03/22/2023
LITERAL MARK ELEMENT IRELYMI

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT IRELYMI
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME AstraZeneca AB
ADDRESS Astraallén
Södertälje, SE-15185
ENTITY 03-CORPORATION
CITIZENSHIP Sweden

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations and substances for the treatment of amyloidosis

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO


FOREIGN INFORMATION
PRIORITY CLAIMED SEC. 44(D) ON Office for Harmonization in the Internal Market (Trade Marks and Designs) (OHIM)
APPLICATION NO. 018681430
APPLICATION FILING DATE 04/04/2022
FOREIGN REG NO. 018681430
FOREIGN REG DATE 07/15/2022
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 04/04/2032
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
03/22/2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
03/22/2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
03/22/2023 ALIE A ASSIGNED TO LIE 008
01/06/2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
12/14/2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
12/14/2022 GNRT F NON-FINAL ACTION E-MAILED 005
12/14/2022 CNRT R NON-FINAL ACTION WRITTEN 004
12/12/2022 DOCK D ASSIGNED TO EXAMINER 003
04/11/2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED 002
04/09/2022 NWAP I NEW APPLICATION ENTERED 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Cara M. Kearney
CORRESPONDENCE ADDRESS Cara M. Kearney
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, A2C
WILMINGTON, DE 19850-5437
DOMESTIC REPRESENTATIVE Cara M. Kearney

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed